Pulmonary Arterial Hypertension (PAH) Treatment Market By Drug Class (Endothelin Receptor Antagonists (ERAs), Vasodilators, Phosphodiesterase-5 (PDE-5) Inhibitors, Soluble Guanylate Cyclase (sGC) Stimulators, Calcium Channel Blockers (CCBs), Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global pulmonary arterial hypertension (PAH) treatment market accounted for a value of US$ 7,802.9 Mn in 2017 and expected to attain US$ 14,642.1 Mn by 2026. Drivers accountable for the market growth are worldwide growing elderly population along with increasing prevalence of pulmonary arterial hypertension due to rising risk factors such as connective tissue disorders, human immunodeficiency virus (HIV) infection, chronic liver diseases, lung diseases, sedentary lifestyle, and other idiopathic conditions.

Raynaud’s Disease (Raynaud’s Syndrome/ Raynaud’s Phenomenon) Therapeutics Market - Growth, Future Prospects, And Competitive Analysis, 2018-2026

$ 4325

As per Cleveland Clinic, primary Raynaud’s phenomenon affects around 5% to 10% of the general population. This phenomenon is predominantly observed among the female population aged 15 to 30 years. Secondary Raynaud’s phenomenon is comparatively more prevalent as its occurrence is associated with the presence of autoimmune diseases. Raynaud’s disease occurs in 90% to 95% of scleroderma patients, 85% of mixed connective tissue disease patients, 40% of systemic lupus erythematous patients and 40% of antisynthetase syndrome patients.

Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Treatment Market - Growth, Future Prospects, And Competitive Analysis, 2018-2026`

$ 4325

The incidence of radiation toxicity is on a rise with increase in treatment and diagnosis of various diseases using radiation therapy and nuclear medicine, thus driving the overall market growth. Cancer treatment predominantly utilizes radiation therapy to treat tumours and cancerous cells. Growing prevalence of cancer thus increases the rate of radiation therapy indicating growing risk of radiation toxicity.

Psoriatic Arthritis Treatment Market - Growth, Future Prospects & Competitive Analysis, 2018-2026

$ 4325

The Arthritis Foundation defines psoriatic arthritis as an autoimmune inflammatory disease which primarily affects the skin. Majorly 30% of the patients suffering with psoriasis develop psoriatic arthritis during the later stages of the disease. Psoriatic arthritis affects men and women equally with the global prevalence rate of 6 per 100,000 people.

Premature Ejaculation Treatment Market By Drug Class (Selective Serotonin Reuptake Inhibitor, Tricyclic Antidepressant, Topical Anesthetic Agent, Phosphodiesterase Type 5 Inhibitors, Others), By Route Of Administration (Oral Route, Topical Route) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The premature ejaculation treatment market is set to reach US$ 3,541.4 Mn by 2026 from US$ 1,666.1 Mn in 2017 showcasing progressive growth at a compound annual growth rate (CAGR) of 8.8% during the forecast period from 2018 to 2026. According to the research survey conducted by the International Journal of Impotence Research (IJIR), 30% adult men throughout the globe suffer with premature ejaculation.

Postpartum Depression Treatment Market - Growth, Future Prospects, And Competitive Analysis, 2018-2026

$ 4325

The American College of Obstetricians and Gynecologists states that around 5%-25% pregnant women experience postpartum depression in America. This growing prevalence primarily contribute to the lucrativeness of this market. Rising awareness among women with respect to postpartum depression has further catalysed the market growth. Growing research activities among leading industries in developing suitable pharmacological treatment option increases the market attractiveness and inclination of women towards timely treatment.

Population Health Management Market By Product (Software, Services), By End User (Providers, Payers, Employer Groups) - Growth, Future Prospects And Competitive Landscape, 2018 – 2026

$ 4325

The population health management (PHM) market is set to reach US$ 81,539.8 Mn by 2026 from US$ 21,079.9 Mn in 2017 projecting impressive growth at a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. PHM solutions are capable to perform tedious task associated with financial, clinical and operational data to refine workflow and patient care.

Pigmentation Disorders Treatment Market By Treatment Type (Topical Drugs, Chemical Peels, Microdermabrasion, Phototherapy, Laser Therapy), By Disease Type (Melasma, Albinism, Vitiligo, Post-Inflammatory Hyperpigmentation, Others) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The pigmentation disorders treatment market is set to reach US$ 9,649.9 Mn by 2026 from US$ 5,311.5 Mn in 2017 showcasing a steady growth at a compound annual growth rate (CAGR) of 6.9% during the forecast period from 2018 to 2026.

Pancreatic Fistula Treatment Market By Treatment Type (Drugs, Surgical Devices) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The pancreatic fistula treatment market stood at US$ 1,708.6 Mn in 2017 and projected to exhibit compound annual growth rate (CAGR) of 5.7% during the forecast period from 2018 to 2026. The International Study Group for Pancreatic Fistulas (ISGPF), defines post-operative pancreatic fistula as ‘external fistula with a drain output of any measurable volume after post-operative day three with an amylase level greater than three times the upper limit of the normal serum value’.

Hemodialysis And Peritoneal Dialysis Market By Type (Hemodialysis, Peritoneal Dialysis), By Product (Services, Devices, Consumables) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The hemodialysis and peritoneal dialysis market is valued at US$ 63,796.2 Mn in 2017 and is set to grow with a compounded annual growth rate (CAGR) of 6.2% during the forecast period from 2018 to 2026. According to the latest research citing of National Kidney Foundation 10% of the global population is suffering with chronic kidney disease eventually resulting into mortality of millions of people annually due to lack of access to effective treatment.

Weight Management Market By Weight Loss Products Type (Dietary Products, Drugs & Supplements, and Cosmetics), By Fitness Equipment Type (Cardio Training Equipment, Strength Training Equipment, Body Composition Analyzers, and Fitness Monitoring Equipment), By Surgical Services Type (Invasive Surgeries, And Non-Invasive Surgeries) - Growth, Future Prospects, And Competitive Analysis, 2016 - 2024

$ 4325

The report titled “Weight Management Market- Growth, Future Prospects, and Competitive Analysis, 2016 – 2024” offers strategic insights into the overall weight management market along with the market size and estimates for the duration 2014 to 2024. The said research study covers in-depth analysis of multiple market segments based on type of weight loss products, fitness equipment, surgical services and different geographies. Weight management market is a dynamic market; the companies are expected to keep in the mind that people nowadays are watching weight rather than dieting. Hence, the products should be positioned in the market as fitness contributors.

Recombinant Plasma Protein Therapeutics Market By Drug Class (Recombinant Factor VIII and Recombinant Factor IX), By Cell Line (Chinese Hamster Ovary, Baby Hamster Kidney and Human Embryonic Kidney and Other), By Indication (Hemophilia A, Hemophilia B, Von Willebrand Disease and Other) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The recombinant plasma protein therapeutics market is set to grow from US$ 7,788.9 Mn in 2017 to US$ 15,910.5 Mn in 2026 expanding at an annual growth rate of 8.3% during the forecast period from 2018 to 2026. According to World Federation of Hemophilia (WFH), approximately 1 in 1,000 people worldwide suffer with some form of bleeding disorder, 75% of them gain inadequate treatment and remain undiagnosed.

Gonorrhea Diagnostics Market - Growth, Future Prospects & Competitive Analysis, 2018-2026

$ 4325

Gonorrhea is caused due to the infection of bacterium Neisseria gonorrhea which usually affects the moist and warm areas of the body such as vagina, anus, urethra, throat and eyes. It is classified as the second most occurring sexually transmitted disease (STD) as it has the risk to spread through unprotected sex or having multiple sex partners. Due to high morbidity rate and eminent threat of gonorrhea being resistant to cephalosporin, makes it necessary to understand the disease epidemiology of gonorrhea.

Proton Therapy Market By Type (Compact Systems, Multiple Rooms Systems), By Indication (Pelvic Cancers, Thorax Area Cancers, Gastrointestinal Cancers, Pediatric Tumors, Lymphomas, Head And Neck Cancers, Brain Cancer, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

Interest in investing and developing in proton therapy has exponentially increased over the past few decades, including the clinical advantage of Bragg peak dose as against the conventional high-energy X-ray distribution of photons.

Pressure Ulcer Treatment Products Market By Product Type (Pressure Relief Devices, Wound Dressings, Wound Care Devices, Others), By Wound Type (Stage 1 & 2, Stage 3 & 4, Unstageable And Deep Tissue Injury), By Usage Area (Hospitals, Nursing Homes, Home Care) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

In the U.S. the prevalence of pressure ulcers in intensive care units ranges from 16.6% to 20.7%. It is also reported that annually US$ 11 billion is spent on the treatment of pressure ulcers, with US$ 500 to US$ 70,000 spent on a single wound.

Precision Medicine Market By Applications (Oncology, Cardiovascular Diseases, Central Nervous System, Infectious Diseases) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

$ 4325

This report titled precision medicine market studies various technology type, application type and geographical scenario. In July 2016, The White House announced that it is giving out USD 55.0 million to a collection of hospitals and companies to uncover links between a person’s genome and disease and built a genetic database of initially at least 1 million Americans. Market experts suggest that the proposed initiative has two main components: a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.

Geriatric Care Services Market By Service Type (Skilled Nursing Care Facilities, Home Healthcare Services, Social Services, Continuing Care Retirement Communities, Assisted Living Facilities), By Service Provider (For-profit, Non-profit), By Payment Source (Public Expenditure, Private Expenditure, Out Of Pocket) - Growth, Share, Opportunities & Competitive Analysis, 2018 – 2026

$ 4325

The global geriatric population is rising at an unprecedented rate. The pool of population aged 60 years is anticipated to double until 2050 and more than triple by 2100 (rising from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100). Aging of population has profound effects in terms of disease burden and social and healthcare systems.

Foot And Mouth Disease (FMD) Vaccines Market By Vaccine Type (Conventional Vaccines, Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Swine, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global foot and mouth disease (FMD) vaccines market to reach US$ 2,935.1 Mn in 2026 and projected to exhibit a compound annual growth rate (CAGR) of 8.1% during the forecast period from 2018 to 2026. FMD is highly contagious viral disease and sometimes fatal affecting cloven hoofed animals that includes domestic and wild bovids.

Equine Healthcare Market By Product Type (Drug Type, Vaccine Type,Supplements and Additives), By Disease Type (West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus)- Growth, Future Prospects & Competitive Analysis, 2018 - 2026

$ 4325

The global equine healthcare market held US$ 626.2 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 4.0% during the forecast period from 2018 to 2026. Growing trend of horse breeding and horse riding for leisure purpose is the major growth factor of the equine healthcare market. Other factors such as growing incidence of equine infections and development of novel animal safety and health programs will continue to assist the growth of the market.

Electronic Health Records (EHR) Market By Delivery (On-Premise Server Based, Cloud-Based, Web-Based), By Product (Inpatient HER, Ambulatory HER), By End-User (Hospitals, Clinics And Diagnostic Centers, Ambulatory Care Centers, Others) - Growth, Future Prospects & Competitive Analysis, 2018 – 2026

$ 4325

The global electronic health records (EHR) market held US$ 24,222.5 Mn in 2017 and expected to grow at compound annual growth rate (CAGR) of 5.9% during the forecast period from 2018 to 2026. EHRs are digital form of patient’s medical chart that deliver real-time patient records providing information instantly and securely to authorized user for medical decision making.